As of 2024-12-14, the Intrinsic Value of ImmuPharma PLC (IMM.L) is
-9.93 GBP. This IMM.L valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.15 GBP, the upside of ImmuPharma PLC is
-963.32%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-9.93 GBP
Intrinsic Value
IMM.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-9.93 - -9.93 |
-9.93 |
-963.32% |
| P/E |
(9.91) - (11.83) |
(9.64) |
-937.9% |
| DDM - Stable |
(3.95) - (14.41) |
(9.18) |
-898.3% |
| DDM - Multi |
(2.87) - (8.86) |
(4.41) |
-483.9% |
IMM.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4.64 |
| Beta |
-0.11 |
| Outstanding shares (mil) |
4.04 |
| Enterprise Value (mil) |
3.56 |
| Market risk premium |
5.98% |
| Cost of Equity |
13.83% |
| Cost of Debt |
5.00% |
| WACC |
9.16% |